Research

No Applicants  // Limit: 2* // Tickets Available: 2

*An eligible applicant may submit up to two LOIs for consideration, but only one (1) LOI may be selected.

Deadlines:

• Required Letter of Intent: May 28, 2024
• Invited Full Proposal: Sep. 6, 2024

The Military Health System Research Program (MHSRP) provides research grants on topic areas directed by the Office of the Assistant Secretary of Defense for Health Affairs (OASD (HA)) and the Leadership of the Defense Health Agency (DHA). The intent of MHSR is to foster research capability and capacity that supports the Military Health System (MHS) as a learning health system and to mature as an integrated health system focused on Ready Reliable Care that improves outcomes for patients, staff, and the enterprise.

The MHSRP funds research that examines factors that affect the enterprise in terms of economics/cost, quality, outcomes, variation, policies, and how they impact health readiness. The goal is to identify and characterize the factors that influence the efficiency and effectiveness of MHS care delivery. Knowledge obtained from this research should support evidence-based policy and decision-making at the strategic and front-line levels. This Notice of Funding Opportunity (NOFO) seeks rigorous collaborative health system research that has the potential to innovate military and civilian health care. The goal is to enhance data-driven evidence that optimizes the MHS delivery of health care and improves the health of beneficiaries. This NOFO is intended to solicit Intramural and Extramural Military Health System Research aligned with DHA priority research areas.

Areas of Interest:

Research must examine the organization, delivery, and financial cost of healthcare, producing evidence that impacts policy and decision-making within the MHS. The research must enhance the efficiency and effectiveness of the MHS to be considered for funding. The research aims should address at least one of the Priority Topic Area(s).

a. Economics and Cost: Research on the factors that shape the MHS cost, drive demand and utilization, and influence cost in either TRICARE direct or purchased care systems; issues related to efficiency, effectiveness, value and behavior in the production, and utilization health care in terms of costs, charges, and expenditures; the impact of technologies on care delivery and cost; and the impact of workforce, recruitment, and retention of medical personnel. Research that delineates value-based care within the MHS in both purchased and direct care; pre- and post- studies to evaluate the impact of the structure of the TRICARE contract on patient care.

b. Quality - Research which examines the degree to which health services for individuals and populations are safe, effective, patient-centered, timely, efficient, and equitable with the outcome of increasing the likelihood of improved health. The impact of standardizing clinical practice through clinical practice guidelines, evidence-based practices, and process improvements, on the health of the population/sub-population.

c. Outcomes - Health outcome research identifies and measures the factors which impact a population of patients at the enterprise, geographic market level, or sub-population levels; examines the system level factors which influence achievement of the Quadruple Aim “better health” in comparison to private sector efforts. Health outcomes research incorporates clinical outcomes, financial impact, patient health, quality of life, and measurement of indicators that predict results important to patients and patient experience.

d. Variation - Studies that examine the factors that influence unwarranted variation or differences in quality, utilization, cost, or outcomes within the MHS and the implications to the enterprise as a system of system of care.

e. Health Readiness - Burden of disease and associated health and risk factors within the MHS populations that effect Active Duty Service Members ability to deploy. Implications of disease burden as an indicator of medical readiness, potential impact to staffing, network utilization, and cost for direct care and/or purchased care.

f. Health System - Research related to the impact of the significant changes in policy or structure of the MHS on health care cost, quality, utilization, health outcomes, manpower/staffing, or health care readiness. Comparisons to between direct and purchased care, or care within the private sector, and includes measurement of the impact of policy changes to the TRICARE benefit structure on utilization and cost.

The proposals must emphasize one of the listed Clinical Priority Areas:
a. Cardiovascular Health
b. Women’s Health
c. Primary Care
d. Specialty Care
e. Sensory Health
f. Dental Care
g. Surgical Care
h. Telehealth
i. Nutritional Care

LOIs and Full Proposals for this funding opportunity may be submitted by investigators, uniformed or civilian staff who work for DoD or non-DoD organizations, as defined below. DHA encourages applications from Minority Serving Institutions (MSI) that include Historically Black Colleges and Universities and others as defined at: https://www.doi.gov/pmb/eeo/doi-minority-serving-institutionsprogram.

a. Extramural Organization: An eligible non-DoD organization. Examples of extramural organizations include academic institutions, nonprofit organizations, and other federal government organizations (other than DoD). • Federally Funded Research and Development Centers (FFRDCs) are not eligible to directly receive awards under this NOFO. However, teaming arrangements between FFRDCs and eligible organizations are allowed if permitted under the sponsoring agreement between the federal government and the specific FFRDC. • Government agencies within the US: Local, state, and non-DoD federal government agencies are eligible to the extent that proposals do not overlap with their fully-funded internal programs. Such agencies are required to explain how their proposals do not overlap with their internal programs.

b. Intramural DoD Organization: A facility or group of facilities owned, leased, or otherwise used by Office of the Secretary of Defense, the Military Departments, the Defense Agencies, and all other organizational entities within the DoD; to include DoD laboratories, DoD MTFs, and/or DoD activities embedded within a civilian medical center.

Submit ticket request  // Limit: 1 // Tickets Available: 1

 Each invited institution may only submit one application to the program which meets the eligibility requirements for the 2025 Grant Cycle. Applicants must be full-time faculty at an invited non-profit academic, medical, non-governmental or research institutions. United States citizenship is not required. Junior faculty are encouraged to apply. 

 The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the prevention of coronary heart disease or circulatory failure and improving care for patients with these medical conditions. The program focuses on basic and translational scientific research. Clinical studies are currently ineligible. 

In accordance with Mr. Geneen’s directives, the program seeks to establish “…a more direct and personalized relationship with grant recipients than is normally possible in dealing with the diffuse and bureaucratic administrations through which large organizations are managed…and to support smaller institutions rather than major universities or medical complexes which have a demonstrated capacity to raise funds from the public generally.” Thus, eligible institutions represent mid-size institutions conducting relevant and innovative cardiovascular research. 

Applications examining the intersection of coronary heart disease and/or congestive heart failure and COVID-19 or similar viral illnesses are highly encouraged to apply. 

Eligibility 

Each invited institution may submit a single application from a full-time faculty member. United States citizenship is not required. To encourage the support of junior faculty, applicants are ineligible if at the time of application, they have combined federal and non-federal funding totaling $500,000 or more in direct costs during the first year of the Geneen Award. This figure refers to external funding only and not an applicant’s start-up package, other intramural support, or the Geneen Award itself. Applicants may hold a K Award or be in the R00 phase of a K99/R00 as long as those award amounts, combined with other funding, do not exceed these specified limits. 

Pending Federal and Non-Federal Support 

Applicants who have pending R01s or other large applications to the NIH and other agencies are encouraged to submit proposals to the Geneen Trust. Notification of funding after the application date will not impact eligibility for a Geneen Award. However, it is the responsibility of applicants to contact GeneenAwards@hria.org as soon as they are notified of any new funding. 

Review Criteria 

• The proposed research has the potential to improve the prevention and treatment of coronary heart disease or circulatory failure (understanding, prevention/treatment). 

• Hypothesis and Research Aims are clearly stated, based on sound precedents, and supported by relevant literature and preliminary data (if applicable). 

• Objectives that are well thought out, realistic, and technically feasible. 

• Research methodology, data collection, and data analyses are appropriate, thorough, well-specified and appropriate to the proposal’s aims. 

• The research project is of high quality and originality. 

• The timeline and budget align with a scope of work that can be completed within a two-year timeframe. 

• The applicant is qualified and supports the conduct of an innovative and successful research project. The research award would positively impact the development of the applicant’s cardiovascular research program. 

In order for the Harold S. Geneen Charitable Trust (the “Funder”) and Health Resources in Action (the “Administrator”) to carry out our legal responsibilities, we must ask the award recipient (the “Recipient”) and the Recipient’s institution (the “Institution”) as identified in the Application to read and acknowledge this award agreement (the “Agreement”) for Recipient’s proposed project submitted to the Administrator (the “Project”). The Agreement specifies the Recipient’s and Institution’s obligations for the duration of this award as identified above. 

Award Amount and Funding Period: Awards are made according to the stated schedule. Recipients may postpone the start date for up to three (3) months without an approval, but the revised date must be noted either on the signature page of this Agreement or by an email notification to the Administrator. Longer delays must be approved by the Administrator. A delayed start date will not reduce the total award period but will adjust the schedule out to include the entire period. 

Awards are made to non-profit academic, medical, non-governmental or research institutions within the United States on behalf of the Recipients. The Institution is responsible for the administrative and financial management of the Project, including any subcontracts, and maintaining adequate supporting records and receipts of expenditures. 

No Applicants // Limit: 1 // Tickets Available: 1 

This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. Project goals should not be achievable with a collection of individual efforts or projects. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

This FOA is not intended for applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development.

No Applicants // Limit: 2 // Tickets Available: 2 

The PRINT program aims to transform organ biofabrication by leveraging recent advances in 3D bioprinting, cell manufacturing, biomaterials, modeling, and tissue engineering. The PRINT program will assemble the necessary tools to facilitate production from a human cell source to a patient matched biofabricated organ to restore at least 40% normal organ function as demonstrated in a large animal model. 

Areas of Interest:

• Technical Area 1 (TA1): Generation of all necessary organ cell types (Phase I)
• Technical Area 2 (TA2): Large scale manufacturing of organ cell types (Phase I & II)
• Technical Area 3 (TA3): Organ Biofabrication and in vivo testing (Phase I and II)

Submit ticket request  // Limit: 2*  // Tickets Available: 1 (Senior Scholar)

Junior Scholar: H. Kornstein (Public & Applied Humanities)

*UA may nominate one Junior Scholar and one Senior Scholar.
Due to the competitive nature of this funding program, the internal selection process will be held with an anticipated deadline. Based on previous funding cycles, UA anticipates a sponsor deadline of November 14, 2024. 
 

The fellows program was established in 2015 to provide philanthropic support to extraordinary scholars and writers for high-caliber research in the humanities and social sciences.  Fellowships of $200,000 are awarded annually to exceptional scholars, authors, journalists, and public intellectuals. The criteria prioritize the originality and promise of the research, its potential impact on the field, and the scholar’s plans for communicating the findings to a broad audience. The funding is for a period of one or two years with the anticipated result of a book or major study. Regardless of title, a junior scholar is defined as someone who received their PhD within the last 10 years (2013–2024, for the 2025 fellowship program).

Through the study of political polarization in the United States, the Corporation seeks to raise awareness in the philanthropic sector, guide public policy, and help inform the foundation’s grantmaking in democracy, education, and international peace and security. 

Focus Areas:

• The Corporation anticipates that the work of the Andrew Carnegie Fellows Program will explore the many ways political polarization in the United States manifests itself in society and suggest ways that it may be mitigated. Studies of polarization in other countries will be considered providing they offer lessons that can be applied to the United States.

Evaluation criteria: 

• Originality and promise of the idea 
• Quality of the proposal 
• Potential impact on the field 
• Record of the nominee 
• Plans to communicate findings to a broad audience

Resubmissions:

•  You may be nominated for the Fellows Program multiple times. However, we strongly recommend that applicants make substantive changes to their applications, as proposals identical to those not previously selected are less likely to be successful.

No Applicants  // Limit: 3 // Tickets Available: 3 

Applicant institutions are limited to no more than 3 letters of intent, pre-applications, or applications as the lead institution per research area. There is no limitation to the number of applications on which an institution appears as a subrecipient or for which the institution is not the lead in a multi-institution team using collaborative applications.

The DOE SC program in Advanced Scientific Computing Research (ASCR) hereby announces its interest in basic computer science and applied mathematics research in the fundamentals of Artificial Intelligence (AI) for science. Specifically, advancements in this area are sought that can enable the development of: 

• Foundation models for computational science;
• Automated scientific workflows and laboratories;
• Scientific programming and scientific-knowledge-management systems;
• Federated and privacy-preserving training for foundation and other AI models for science; and
• Energy-efficient AI algorithms and hardware for science.

Limit: 1 // Tickets Available: 1

This request for applications is specifically for pediatric cancer research through the Translational grant mechanism. Applicants may propose pediatric cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.

Research areas not included in this scope are epidemiology, behavioral science, and health services research.

For more information please contact UACC-preaward@arizona.edu.

No Applicants  // Limit: 5 // Tickets Available: 5 

Applicant institutions are limited to both: 

• No more than a total of five pre-applications or applications as the lead institution in a single- or multi-institutional team.
• No more than one pre-application or application for each PI at the applicant institution.

Extreme-scale science recognizes that disruptive technology changes are occurring across science applications, algorithms, computer architectures and ecosystems. Recent reports point to emerging trends and advances in high-end computing, massive datasets, visualization, and artificial intelligence on increasingly heterogeneous architectures. Significant innovation will be required in the development of effective paradigms and approaches for realizing the full potential of scientific computing from emerging technologies. Proposed research should not focus on a specific science use case, but rather on creating the body of knowledge and understanding that will inform future advances in extreme-scale science. Consequently, the funding from this FOA is not intended to incrementally extend current research in the area of the proposed project. It is expected that the proposed projects will significantly benefit from the exploration of innovative ideas or from the development of unconventional approaches.

No Applicants // Limit: 5 // Tickets Available: 2

1. J.M. Roveda (Electrical Engineering and Computer Sciences) -- TA Pending
2. J.M. Roveda (Electrical Engineering and Computer Sciences) -- TA Pending
3. S.  Adhikari (Emergency Medicine) -- TA5: Intelligent Task Guidance.

An organization may submit up to two abstracts per technical area (TA) but may only submit one proposal for each technical area per section 1.3.1 of the Solicitation. All abstracts will be evaluated independently regardless of their affiliation.

The Platform Accelerating Rural Access to Distributed and InteGrated Medical Care (PARADIGM) program aims to address the current challenges in rural health by creating a scalable vehicle platform that can provide advanced medical services outside of a hospital setting. Building on recent developments in fields ranging from satellite communication to medical device miniaturization, this mobile care platform will allow health providers to meet rural patients where they are.  

In order to create a platform that can bring sophisticated medical services to the doorstep of rural populations, PARADIGM will focus on five technical areas: 1) designing distributed hospital-level care, 2) producing an integrated care delivery platform, 3) harmonizing diverse medical device data within a single system, 4) building a miniaturized, ruggedized CT scanner, and 5) creating intelligent task guidance software to help health workers perform activities beyond their usual training.  

If successful, PARADIGM hopes to develop a mobile platform capable of delivering many different types of cutting-edge services – including multi-cancer screenings, hemodialysis, perinatal care, and much more. With medical technology no longer tied to a specific place – but instead available on a platform that can travel to even the most remote locations – rural patients will thus be able to access the care that they need within their own communities. 

Technical Areas (TAs):

• TA1: Decentralized Approach to Hospital-Level Care. Provide clinical care in a CDP that is currently only available in a hospital, and evaluate the clinical effectiveness, financial sustainability, and patient/staff user acceptability of CDP-based care.
• TA2: Care Delivery Platform Integration. Develop a multipurpose scalable CDP to deliver advanced care outside the walls of a hospital.
• TA3: Medical Internet of Things (IoT) Platform. Develop a low-cost software platform that enables seamless data ingestion, normalization, and translation between common medical devices and commercial or open-source EHR.
• TA4: Rugged & Miniaturized CT Scanner. Fundamentally redesign and miniaturize a CT scanner for use in out-of-hospital settings to enable utilization of this essential imaging modality in remote rural populations.
• TA5: Intelligent Task Guidance. Develop and equip CDP staff with an easy-to-use and interactive intelligent task guidance system that will provide real-time task guidance and decision support and turn a generalist into a just-in-time specialist

Limit: 1 //   E. Thornley (Child Health)

American Skin Association (ASA) is accepting applications for support of research in melanoma and skin cancer. ELIGIBILITY: Applicants must be working actively in areas related to dermatology targeting melanoma and skin cancer. Funds may be used for support of a new or ongoing research/clinical investigation project. There is no age requirement. However, applicants without prior funding, who are in a formative stage of their career, or who are undergoing a mid-career research change, will be given preference. CONTENTS OF APPLICATION: An application must include: 1. A letter from the applicant stating: a. a lay statement of 2-3 sentences describing the relevance of the proposed research b. career goals c. relevance of the grant at this time d. acknowledgment of the requirement to submit a progress report (written in layman’s language) and an expenditure report at the end of the grant period e. acknowledgement of the requirement to list ASA support in all presentations/publications f. acknowledgement to keep ASA informed of current and future dates of presentations and/or publications